Megan Molteni is a science writer at STAT. She covers genomic medicine, neuroscience, and reproductive technology, with a keen interest in the intersection of science and public health. Her work has been featured in PBS, The Boston Globe, WIRED, and other notable publications, and she is recognized for her award-winning feature on aerosol science and Covid-19 public health policy.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Megan Molteni's coverage primarily revolves around scientific and healthcare topics, with a focus on data-driven reporting. Given her emphasis on citing data and press releases, she is likely to be particularly interested in pitches that provide access to exclusive or compelling research findings within the fields of CRISPR, genetic engineering, AI in medicine, gene therapies, and other innovative medical technologies.
Her articles also suggest an international scope as she covers global developments in science and healthcare. Therefore, experts from various geographical locations who can contribute unique insights into these evolving areas would find favor with her.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Anil Oza, Megan Molteni
The White House is asking Congress to cut $5 billion from the National Institutes of Health and downsize the number of its institutes and centers from 27 to 22 — a plan that is expected to receive a chilly reception from lawmakers.
By: Megan Molteni
E Every year, the Genetics Society of America bestows the Elizabeth W. Jones Award for Excellence in Education, recognizing someone who has helped the public better understand the science of DNA.
By: Megan Molteni
Deadline for an appeal to the U.S. Supreme Court passed this week
By: Megan Molteni
An integrative medicine doctor who is the wife of the acting U.S. attorney general has been named as a member to one of the advisory councils that provides critical funding recommendations to the NIH.
By: Megan Molteni
Scientists discover novel microproteins involved in gene regulation, immune responses, and cancer
By: Megan Molteni
UCSF team are in advanced talks with the FDA about first-in-human study of in utero gene therapy
By: Megan Molteni
OHRP has experienced an unprecedented exodus of ethics expertise, raising concerns about its ability to effectively protect volunteers.
By: Megan Molteni
A new study found that the number one environmental factor influencing brain structure and function is the socioeconomic status of a child's family.
By: Megan Molteni
As the Human Cell Atlas project marks its 10th anniversary, a leader's ties to a major single-cell RNA sequencing company raise conflict-of-interest questions.
By: Andrew Joseph, Megan Molteni
Researchers are using the tools for basic scientific inquiries, while also underscoring their potential
